PUBLIC COMPANY
saveDr. Reddy's Laboratories Ltd
updated 21d ago
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
community read0 votes
🐶 often sniffed alongside
top 8- tagRecall21 co-mentions · 12 sources
- drugRNS-606 co-mentions · 1 sources
- druglevetiracetam ER6 co-mentions · 1 sources
- druglevetiracetam ODT6 co-mentions · 1 sources
- drugLEVETIRACETAM6 co-mentions · 1 sources
- drugOXYCODONE HYDROCHLORIDE AND IBUPROFEN5 co-mentions · 2 sources
- drugomeprazole DR4 co-mentions · 1 sources
- drugIBUPROFEN4 co-mentions · 2 sources
pipeline
16
marketed
13
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(16)
view full pipeline →pipeline depth16 products
13Marketed2pre_registration1Unknown
Marketed
(ethinylestradiol + etonogestrel) SR
Female Contraception
Marketed(metformin hydrochloride + saxagliptin) ER
Type 2 Diabetes
MarketedMyezom
Mantle Cell Lymphoma
MarketedRezipres
Hypotension
Marketedclocortolone pivalate
Psoriasis
Marketedclonidine
Hypertension
Marketedcycloserine
Pulmonary Tuberculosis
Marketeddesloratadine ODT
Perennial Allergic Rhinitis
Marketeddisopyramide phosphate
Ventricular Arrhythmia
Marketedenalaprilat
Hypertension
Marketedfluoxetine hydrochloride DR
Major Depressive Disorder
Marketedpancuronium bromide
Muscle Relaxation
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants
- phase3Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma
- phase3A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products
- phase1Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that